81 related articles for article (PubMed ID: 3797346)
1. [Ferritin in breast cancer].
Góźdź S; Słuszniak J; Bukowski J; Zagała A; Kowalski D; Korejba W; Banasińska E; Cheba L
Pol Tyg Lek; 1986 Sep; 41(35):1110-2. PubMed ID: 3797346
[No Abstract] [Full Text] [Related]
2. The significance of tumor marker assay in the staging of breast cancer. Assessment of ferritin and beta-HCG levels.
Micali B; Gioffrè Florio MA; Venuti A; Giorgianni G; Saitta FP
J Nucl Med Allied Sci; 1981; 25(3):65-70. PubMed ID: 7310528
[No Abstract] [Full Text] [Related]
3. [Evaluation of ferritin, CEA and AFP in patients operated on for carcinoma of the breast. Preliminary results].
Latteri M; Spinnato G; Pantuso G; Di Lisi G; Latteri S; Bellanca L; Latteri MT; Cirello B; Ciaccio M
Minerva Chir; 1987 May; 42(10):911-6. PubMed ID: 2442669
[No Abstract] [Full Text] [Related]
4. [Serum ferritin level in patients with breast cancer].
Rusinowska Z; Rozek-Lesiak K; Kokocińska D
Pol Tyg Lek; 1988 May; 43(22):706-8. PubMed ID: 3226979
[No Abstract] [Full Text] [Related]
5. [Preliminary observations on the behavior of serum ferritin in female patients with breast cancer at various stages of the disease].
Dell'Anna B; Carnevali C; Crialesi Esposito G; Percudani M
Acta Biomed Ateneo Parmense; 1982; 53(3):147-51. PubMed ID: 6216702
[TBL] [Abstract][Full Text] [Related]
6. [Relation of blood serum ferritin and ferritin-bearing lymphocytes in breast cancer].
Chernovskaia EM; Polevaia EB; Tuzhikova NK
Med Radiol (Mosk); 1986 Apr; 31(4):15-7. PubMed ID: 3959805
[TBL] [Abstract][Full Text] [Related]
7. Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay.
Bluestein BI; Luderer AA; Hess D; Smith D; Meyer KK; Boyle G; Carter AC
Cancer Res; 1984 Sep; 44(9):4131-6. PubMed ID: 6744324
[TBL] [Abstract][Full Text] [Related]
8. [Serum levels of 4 tumor-associated antigens in the evaluation of the spread of breast carcinoma].
Stefanović L; Kamenjicki E; Selir Z; Miljković L; Sterio B; Semnic R; Sljapić N
Med Pregl; 1984; 37(3-4):107-12. PubMed ID: 6208469
[No Abstract] [Full Text] [Related]
9. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast.
Kher A; Moghe G; Deshpande A
Indian J Pathol Microbiol; 1997 Jul; 40(3):321-6. PubMed ID: 9354001
[TBL] [Abstract][Full Text] [Related]
10. [The value of evaluating tumor markers: CA 15-3 and ferritin in blood serum of patients grouped as "high risk" for breast cancer].
Kokocińska D; Widala E; Donocik J; Nolewajka E
Przegl Lek; 1999; 56(10):664-7. PubMed ID: 10695382
[TBL] [Abstract][Full Text] [Related]
11. [The diagnostic value of serum ferritin determination in cancer patients].
Chen SB
Zhonghua Zhong Liu Za Zhi; 1984 Jan; 6(1):30-2. PubMed ID: 6745047
[No Abstract] [Full Text] [Related]
12. [What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters].
Dalifard I; Daver A; Cellier P; Larra F
Sem Hop; 1984 Jan; 60(3):157-62. PubMed ID: 6320439
[TBL] [Abstract][Full Text] [Related]
13. [Ferritin and breast cancer].
Claustres M; Belaroussi N; Guilleux F; Magnan de Bornier B
Pathol Biol (Paris); 1984 Apr; 32(4):265-8. PubMed ID: 6718068
[TBL] [Abstract][Full Text] [Related]
14. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
15. [Serum ferritin assay in the evaluation of the loco-regional spread of gastric cancer].
Gioffré Florio MA; Venuti A; Caputo G; La Rosa M; Giorgianni G; Micali B
Bull Cancer; 1983; 70(3):174-6. PubMed ID: 6882933
[No Abstract] [Full Text] [Related]
16. [Usefulness of measuring serum ferritin in the diagnosis and staging of non-microcytoma bronchial carcinoma].
Rapellino M; Baldi S; Obert R; Pecchio F; Oliaro A; Mancuso M
Minerva Med; 1986 Dec; 77(47-48):2221-2. PubMed ID: 3808380
[TBL] [Abstract][Full Text] [Related]
17. [Tumor markers in breast cancer].
Polevaia EB; Tkacheva GA; Letiagin VP; Ivanov VM; Koposova TL
Sov Med; 1985; (3):25-9. PubMed ID: 4023831
[No Abstract] [Full Text] [Related]
18. Ferritin levels and circulating immune complexes in patients with solid tumors.
Celada A; Barnet M; Aguado MT; Cruchaud A; Lambert PH
Bull Cancer; 1982; 69(1):22-7. PubMed ID: 6978747
[TBL] [Abstract][Full Text] [Related]
19. Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.
Pattanapanyasat K; Hoy TG; Jacobs A; Courtney S; Webster DJ
Br J Cancer; 1988 Feb; 57(2):193-7. PubMed ID: 2965916
[TBL] [Abstract][Full Text] [Related]
20. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
Di Martino G; Iannucci F; Bizzarro A; Iacono G
Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
